Interferon beta-1a biosimilar (Biosidus)

干扰素β-1a生物类似药 (Biosidus)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon beta-1a biosimilar (Biosidus)

Drug Alias Name干扰素β-1a生物仿制药 (Biosidus)Interferon beta 1a (Biosidus )Blastoferon

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionImmunomodulatorsInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesBiosidus

China Registration ClassN/A

Active CompaniesBiosidus

Inactive CompaniesN/A

Active IndicationsMultiple Sclerosis

Inactive IndicationsN/A

ATC CodeL03AB07